These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16932586)

  • 1. Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?
    Lindhorst S; Cudkowicz M
    Nat Clin Pract Neurol; 2006 Jul; 2(7):364-5. PubMed ID: 16932586
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
    Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
    Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining survival as an outcome measure in amyotrophic lateral sclerosis.
    Gordon PH; Corcia P; Lacomblez L; Pochigaeva K; Abitbol JL; Cudkowicz M; Leigh PN; Meininger V
    Arch Neurol; 2009 Jun; 66(6):758-61. PubMed ID: 19506136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic trials in amyotrophic lateral sclerosis.
    Olarte MR
    Adv Neurol; 1982; 36():555-7. PubMed ID: 6758531
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of vascular inner ear disease with pentoxifylline: a 4-week, controlled, randomized trial.
    Incandela L; Cesarone MR; Belcaro G; De Sanctis MT; Nicolaides AN; Griffin M; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S19-22. PubMed ID: 11865830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis.
    Thornhill MH; Baccaglini L; Theaker E; Pemberton MN
    Arch Dermatol; 2007 Apr; 143(4):463-70. PubMed ID: 17438178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urticaria caused by pentoxifylline.
    Seoane-Lestón FJ; Añibarro-Bausela MB; Mugíca-García MV; Aguilar-Martínez A
    J Investig Allergol Clin Immunol; 2009; 19(1):74-5. PubMed ID: 19274940
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pentoxifylline in the treatment of disorders of the cerebral circulation].
    Drozdov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(9):62-7. PubMed ID: 9410609
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentoxifylline: brief review and rationale for its possible use in the treatment of autism.
    Gupta S; Rimland B; Shilling PD
    J Child Neurol; 1996 Nov; 11(6):501-4. PubMed ID: 9120235
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.
    Shirabe S; Nakamura T; Tsujino A; Nishiura Y; Furuya T; Goto H; Suenaga A; Nakane S; Yoshimura T; Nagataki S
    J Neurol Sci; 1997 Oct; 151(1):97-101. PubMed ID: 9335018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized control trials in ALS: lessons learned.
    Mitsumoto H; Gordon P; Kaufmann P; Gooch CL; Przedborski S; Rowland LP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():8-13. PubMed ID: 15512861
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentoxifylline-induced thrombocytopenia.
    Acharya S; Nair BC
    Int J Dermatol; 1997 Aug; 36(8):635-6. PubMed ID: 9329901
    [No Abstract]   [Full Text] [Related]  

  • 16. Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis.
    Cudkowicz ME; Shefner JM; Simpson E; Grasso D; Yu H; Zhang H; Shui A; Schoenfeld D; Brown RH; Wieland S; Barber JR;
    Muscle Nerve; 2008 Jul; 38(1):837-44. PubMed ID: 18551622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
    Magnusson M; Höglund P; Johansson K; Jönsson C; Killander F; Malmström P; Weddig A; Kjellén E
    Eur J Cancer; 2009 Sep; 45(14):2488-95. PubMed ID: 19540105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of subcutaneous microinjections (mesotherapy) in musicians.
    Navarte DA; Rosset-Llobet J
    Med Probl Perform Art; 2011 Jun; 26(2):79-83. PubMed ID: 21695355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.
    Sorarù G; Pegoraro E; Spinella P; Turra S; D'Ascenzo C; Baggio L; Mantovan MC; Vergani L; Angelini C
    Amyotroph Lateral Scler; 2006 Dec; 7(4):246-8. PubMed ID: 17127564
    [No Abstract]   [Full Text] [Related]  

  • 20. Designing clinical trials in amyotrophic lateral sclerosis.
    Shefner JM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.